@mark-carney.bsky.social
Prime Minister of Canada and Leader of the Liberal Party | Premier ministre du Canada et chef du Parti libéral markcarney.ca
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@kyleserikawa.bsky.social
Scientist. Genetics, genomics, biotech, systems. Interested in all kinds of things.
@michael-schultz.bsky.social
Life sciences VC @Portal Innovations 🔬 Previously @Health Advances 💊 PhD at Harvard with David Sinclair lab on aging🧬 Opinions my own 🤷♂️
@seahawksofficial.com
Go Hawks! Your #1 source for up-to-date news, media, and info for your XLVIII Super Bowl Champion Seattle Seahawks #12s Unaffiliated with The Seattle Seahawks Organization - Fan Account until our Hawks finally join BlueSky :)
@steen1969.bsky.social
Principal at https://liverpoollane.com. Occasionally other stuff...
@susannalharris.bsky.social
Helping scientists communicate. Working in biotech VC, living in San Francisco, reading in every available armchair.
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@nejm.org
Welcome to the official Bluesky account for the New England Journal of Medicine! Follow us for high-quality, peer-reviewed research and clinical content from the world’s leading medical journal and website (NEJM.org).
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: lwu@endpointsnews.com • Signal: leileiwu.24 • ✌️
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or chat me for Signal. he/him
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@oncodaily.bsky.social
Your daily dose of hope, inspiration, and information in the fight against cancer. oncodaily.com
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@urnov.bsky.social
Clinic-minded genome + epigenome editor. Professor of Molecular Therapeutics, UC Berkeley. Director for Technology and Translation, Innovative Genomics Institute, ibid. Beatles fan. Art work credit: Fyodor Vasiliev "A Meadow in the Rain" (1872).
@loftus.bsky.social
Reporter covering drug companies, medical-device companies for The Wall Street Journal. Author of The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@drsam.bsky.social
Pediatric oncologist. Cancer drug developer. Dad joke aficionado. Moth GrandSLAM winner. Climber of mountains. Raconteur. Baker. Orcasonian. Entrepreneur-in-Residence @ GV. I'm also at https://substack.com/@drsamblackman
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & functional longevity. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@carolynbertozzi.bskyverified.social
Baker Family Director, Sarafan ChEM-H, Stanford University and HHMI; EIC of ACS Cent Sci; All views and opinions expressed are my own.
@benthefidler.bsky.social
Biotech journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy. #BioSky
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@cnn.com
Asking the hard questions and bringing unique perspectives from across the globe. This is CNN.
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@seattletimes-rss.bsky.social
An unofficial bot of The Seattle Times rss: https://www.seattletimes.com/seattle-news/feed/ maintainer: @anotherseattleite.bsky.social
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app